| scholarly article | Q13442814 |
| P356 | DOI | 10.1179/JOC.1995.7.4.355 |
| P8608 | Fatcat ID | release_wwlqhffiarfxzkg63i6bpzga2m |
| P698 | PubMed publication ID | 8568546 |
| P2093 | author name string | Conti S | |
| Novelli A | |||
| Mazzei T | |||
| Cassetta MI | |||
| Fallani S | |||
| P2860 | cites work | Comparative in vitro activity of a new quinolone, AM-1091 | Q34675183 |
| Comparison of two methods for determining in vitro postantibiotic effects of three antibiotics on Escherichia coli | Q35298021 | ||
| Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo | Q35354562 | ||
| Concepts on the use of liposomal antimicrobial agents: applications for aminoglycosides | Q35462267 | ||
| Methicillin-resistant staphylococci: detection methods and treatment of infections | Q35566190 | ||
| Once daily aminoglycoside dosing: maintained efficacy with reduced nephrotoxicity? | Q35991121 | ||
| Once-daily aminoglycoside administration: new strategies for an old drug | Q38239743 | ||
| Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. | Q38739367 | ||
| In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones | Q39818149 | ||
| Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model | Q39833928 | ||
| A new method to determine postantibiotic effect and effects of subinhibitory antibiotic concentrations | Q39881971 | ||
| Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital | Q40086702 | ||
| The post-antibiotic effect | Q40804547 | ||
| In vitro susceptibility patterns of methicillin-resistant and-susceptible Staphylococcus auerues strains in a population of parenteral drug abusers from 1972 to 1981. | Q41978904 | ||
| Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
| Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia | Q46611376 | ||
| Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia | Q54259678 | ||
| Automatic procedures for measuring post-antibiotic effect and determining random errors. | Q54625255 | ||
| Lomefloxacin-induced modification of the kinetics of growth of gram-negative bacteria and susceptibility to phagocytic killing by human neutrophils. | Q54720435 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 355-362 | |
| P577 | publication date | 1995-08-01 | |
| P1433 | published in | Journal of Chemotherapy | Q15754073 |
| P1476 | title | In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin. | |
| P478 | volume | 7 |
| Q38402423 | A practical guide to the diagnosis, treatment, and prevention of neonatal infections |
| Q35297198 | Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis |
| Q41578032 | Novel Glycoconjugate of 8-Fluoro Norfloxacin Derivatives as Gentamicin-resistant Staphylococcus aureus Inhibitors: Synthesis and Molecular Modelling Studies |
| Q41963116 | Optimal aminoglycoside therapy following the sepsis: how much is too much? |
| Q41706103 | Pharmacokinetics of drugs used in critically ill adults |
| Q37956403 | Pharmacological considerations for the proper clinical use of aminoglycosides |
| Q42007756 | Post-antibiotic effect of orbifloxacin against Escherichia coli and Pseudomonas aeruginosa isolates from dogs |
| Q33594918 | Postantibiotic leukocyte enhancement of meropenem against gram-positive and gram-negative strains |
Search more.